Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT02900651
Status:
TERMINATED
Last Update Posted:
2025-08-11
First Post:
2016-09-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-02
First Submit QC Date:
None
Study First Post Date:
2016-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-06
Last Update Post Date:
2025-08-11
Last Update Post Date Type:
ACTUAL